Abstract
Frontline Ofatumumab in Combination with Hyper-CVAD for Adult Patients with CD-20 Positive Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have